Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first line treatment of metastatic colorectal cancer
Articles > Article · 2014
Authors: UMUT VAROL, ESIN OKTAY, MUSTAFA YILDIRIM, ZEKI GOKHAN SURMELI, AHMET DİRİCAN, NEZIH MEYDAN, Şaziye Burçak YAYLA, BÜLENT KARABULUT, RUCHAN USLU
MOLECULAR AND CLINICAL ONCOLOGY, Journal Indexed in SCI Expanded, International, Scopus, 2014, vol 2, pp 166-170